查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508451

质子帮浦抑制剂市场 - 全球产业分析、规模、份额、成长、趋势和预测，2024-2034 年

Proton Pump Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 155 Pages | 商品交期: 2-10个工作天内

价格

质子帮浦抑制剂 (PPI) 市场 - 报告范围

TMR 关于全球质子帮浦抑制剂(PPI) 市场的报告研究了过去以及当前的成长趋势和机会，以获得2024 年至2034 年预测期内市场指标的宝贵见解。 PPI) 市场的收入质子帮浦抑制剂（PPI）市场2018-2034年，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球质子帮浦抑制剂（PPI）市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解质子帮浦抑制剂 (PPI) 市场。

市场概况
2023年市场价值 37 亿美元
2034 年市场价值 56 亿美元
复合年增长率 4%

该报告深入研究了全球质子帮浦抑制剂（PPI）市场的竞争格局。全球质子帮浦抑制剂 (PPI) 市场的主要参与者已经确定，并对每位参与者的各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球质子帮浦抑制剂 (PPI) 市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测
  • 波特五力分析

第 5 章：主要见解

  • 监管场景
  • 产品批准/发布
  • 管道分析

第 6 章：全球市场分析与预测：按药物类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按药物类型分類的市场价值预测
    • 奥美拉唑
    • 泮托拉唑
    • 埃索美拉唑
    • 兰索拉唑
    • 雷贝拉唑
    • 其他（右兰索拉唑等）
  • 按药物类型分類的市场吸引力

第 7 章：全球市场分析与预测：依指标类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按指标类型分類的市场价值预测
    • 胃食道逆流疾病
    • 胃溃疡
  • 按指示类型分類的市场吸引力

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 医院药房
    • 零售药局
    • 网路药局
  • 最终用户的市场吸引力

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 10 章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 13 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会
  • 南非
  • 中东和非洲其他地区

第15章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司简介
    • Pfizer
    • Teva Pharmaceutical Industries Ltd.
    • LUPIN Limited
    • Amneal Pharmaceuticals LLC
    • Zydus Cadila
    • Sun Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • Sanofi SA
    • AstraZeneca
Product Code: TMRGL19169

Proton Pump Inhibitors (PPIs) Market - Scope of Report

TMR's report on the global proton pump inhibitors (PPIs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global proton pump inhibitors (PPIs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global proton pump inhibitors (PPIs) market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the proton pump inhibitors (PPIs) market.

Market Snapshot
Market Value in 2023US$ 3.7 Bn
Market Value in 2034US$ 5.6 Bn
CAGR4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global proton pump inhibitors (PPIs) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global proton pump inhibitors (PPIs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global proton pump inhibitors (PPIs) market.

The report delves into the competitive landscape of the global proton pump inhibitors (PPIs) market. Key players operating in the global proton pump inhibitors (PPIs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global proton pump inhibitors (PPIs) market profiled in this report.

Key Questions Answered in Global proton pump inhibitors (PPIs) Market Report:

  • What is the sales/revenue generated by proton pump inhibitors (PPIs) across all regions during the forecast period?
  • What are the opportunities in the global proton pump inhibitors (PPIs) market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Proton Pump Inhibitors (PPIs) Market - Research Objectives and Research Approach

The comprehensive report on the global proton pump inhibitors (PPIs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global proton pump inhibitors (PPIs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global proton pump inhibitors (PPIs) market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Proton Pump Inhibitors (PPIs) Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, 2020-2034
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Regulatory Scenario
  • 5.2. Product Approval/Launches
  • 5.3. Pipeline Analysis

6. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2034
    • 6.3.1. Omeprazole
    • 6.3.2. Pantoprazole
    • 6.3.3. Esomeprazole
    • 6.3.4. Lansoprazole
    • 6.3.5. Rabeprazole
    • 6.3.6. Others (Dexlansoprazole, etc.)
  • 6.4. Market Attractiveness By Drug Type

7. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Indication Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Indication Type, 2020-2034
    • 7.3.1. Gastroesophageal Reflux Disease
    • 7.3.2. Peptic Ulcers
  • 7.4. Market Attractiveness By Indication Type

8. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By End-user

9. Global Proton Pump Inhibitors (PPIs) Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Type, 2020-2034
    • 10.2.1. Omeprazole
    • 10.2.2. Pantoprazole
    • 10.2.3. Esomeprazole
    • 10.2.4. Lansoprazole
    • 10.2.5. Rabeprazole
    • 10.2.6. Others (Dexlansoprazole, etc.)
  • 10.3. Market Value Forecast By Indication Type, 2020-2034
    • 10.3.1. Gastroesophageal Reflux Disease
    • 10.3.2. Peptic Ulcers
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By, 2020-2034
  • 10.6. Market Value Forecast By Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Drug Type
    • 10.7.2. By Indication Type
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2034
    • 11.2.1. Omeprazole
    • 11.2.2. Pantoprazole
    • 11.2.3. Esomeprazole
    • 11.2.4. Lansoprazole
    • 11.2.5. Rabeprazole
    • 11.2.6. Others (Dexlansoprazole, etc.)
  • 11.3. Market Value Forecast By Indication Type, 2020-2034
    • 11.3.1. Gastroesophageal Reflux Disease
    • 11.3.2. Peptic Ulcers
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By, 2020-2034
  • 11.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Drug Type
    • 11.7.2. By Indication Type
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2034
    • 12.2.1. Omeprazole
    • 12.2.2. Pantoprazole
    • 12.2.3. Esomeprazole
    • 12.2.4. Lansoprazole
    • 12.2.5. Rabeprazole
    • 12.2.6. Others (Dexlansoprazole, etc.)
  • 12.3. Market Value Forecast By Indication Type, 2020-2034
    • 12.3.1. Gastroesophageal Reflux Disease
    • 12.3.2. Peptic Ulcers
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By, 2020-2034
  • 12.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. India
    • 12.6.3. Japan
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Drug Type
    • 12.7.2. By Indication Type
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2034
    • 13.2.1. Omeprazole
    • 13.2.2. Pantoprazole
    • 13.2.3. Esomeprazole
    • 13.2.4. Lansoprazole
    • 13.2.5. Rabeprazole
    • 13.2.6. Others (Dexlansoprazole, etc.)
  • 13.3. Market Value Forecast By Indication Type, 2020-2034
    • 13.3.1. Gastroesophageal Reflux Disease
    • 13.3.2. Peptic Ulcers
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By, 2020-2034
  • 13.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Drug Type
    • 13.7.2. By Indication Type
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Proton Pump Inhibitors (PPIs) Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2034
    • 14.2.1. Omeprazole
    • 14.2.2. Pantoprazole
    • 14.2.3. Esomeprazole
    • 14.2.4. Lansoprazole
    • 14.2.5. Rabeprazole
    • 14.2.6. Others (Dexlansoprazole, etc.)
  • 14.3. Market Value Forecast By Indication Type, 2020-2034
    • 14.3.1. Gastroesophageal Reflux Disease
    • 14.3.2. Peptic Ulcers
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By, 2020-2034
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. GCC
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Drug Type
    • 14.7.2. By Indication Type
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Pfizer
      • 15.2.1.1. Company Overview
      • 15.2.1.2. Financial Overview
      • 15.2.1.3. Product Portfolio
      • 15.2.1.4. Business Strategies
      • 15.2.1.5. Recent Developments
    • 15.2.2. Teva Pharmaceutical Industries Ltd.
      • 15.2.2.1. Company Overview
      • 15.2.2.2. Financial Overview
      • 15.2.2.3. Product Portfolio
      • 15.2.2.4. Business Strategies
      • 15.2.2.5. Recent Developments
    • 15.2.3. LUPIN Limited
      • 15.2.3.1. Company Overview
      • 15.2.3.2. Financial Overview
      • 15.2.3.3. Product Portfolio
      • 15.2.3.4. Business Strategies
      • 15.2.3.5. Recent Developments
    • 15.2.4. Amneal Pharmaceuticals LLC
      • 15.2.4.1. Company Overview
      • 15.2.4.2. Financial Overview
      • 15.2.4.3. Product Portfolio
      • 15.2.4.4. Business Strategies
      • 15.2.4.5. Recent Developments
    • 15.2.5. Zydus Cadila
      • 15.2.5.1. Company Overview
      • 15.2.5.2. Financial Overview
      • 15.2.5.3. Product Portfolio
      • 15.2.5.4. Business Strategies
      • 15.2.5.5. Recent Developments
    • 15.2.6. Sun Pharmaceutical Industries Ltd.
      • 15.2.6.1. Company Overview
      • 15.2.6.2. Financial Overview
      • 15.2.6.3. Product Portfolio
      • 15.2.6.4. Business Strategies
      • 15.2.6.5. Recent Developments
    • 15.2.7. Alembic Pharmaceuticals Limited
      • 15.2.7.1. Company Overview
      • 15.2.7.2. Financial Overview
      • 15.2.7.3. Product Portfolio
      • 15.2.7.4. Business Strategies
      • 15.2.7.5. Recent Developments
    • 15.2.8. Sanofi S.A.
      • 15.2.8.1. Company Overview
      • 15.2.8.2. Financial Overview
      • 15.2.8.3. Product Portfolio
      • 15.2.8.4. Business Strategies
      • 15.2.8.5. Recent Developments
    • 15.2.9. AstraZeneca
      • 15.2.9.1. Company Overview
      • 15.2.9.2. Financial Overview
      • 15.2.9.3. Product Portfolio
      • 15.2.9.4. Business Strategies
      • 15.2.9.5. Recent Developments

List of Tables

  • Table 01: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 02: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 03: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 07: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 08: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 09: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 11: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 12: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 15: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 16: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 17: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 19: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 20: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Drug Type, 2020-2034
  • Table 23: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Indication Type, 2020-2034
  • Table 24: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Drug Type, 2023
  • Figure 03: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Indication Type, 2023
  • Figure 04: Global Proton Pump Inhibitors (PPIs) Market Value Share, by End-user, 2023
  • Figure 05: Global Proton Pump Inhibitors (PPIs) Market Value Share, by Region, 2023
  • Figure 06: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 07: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Drug Type, 2023
  • Figure 08: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Drug Type, 2034
  • Figure 09: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 10: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Omeprazole, 2020-2034
  • Figure 11: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Omeprazole, 2023 and 2034
  • Figure 12: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Pantaprazole, 2020-2034
  • Figure 13: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Pantaprazole, 2023 and 2034
  • Figure 14: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Esomeprazole, 2020-2034
  • Figure 15: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Esomeprazole, 2023 and 2034
  • Figure 16: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Lansoprazole, 2020-2034
  • Figure 17: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Lansoprazole, 2023 and 2034
  • Figure 18: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Rabeprazole, 2020-2034
  • Figure 19: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Rabeprazole, 2023 and 2034
  • Figure 20: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Others, 2020-2034
  • Figure 21: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 22: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 23: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Indication Type, 2023
  • Figure 24: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Indication Type, 2034
  • Figure 25: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 26: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Gastroesophageal Reflux Disease, 2020-2034
  • Figure 27: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Gastroesophageal Reflux Disease, 2023 and 2034
  • Figure 28: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Peptic Ulcers, 2020-2034
  • Figure 29: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Peptic Ulcers, 2023 and 2034
  • Figure 30: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 31: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Distribution Channel, 2023
  • Figure 32: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Distribution Channel, 2034
  • Figure 33: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 34: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Hospitals Pharmacies, 2020-2034
  • Figure 35: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Hospitals Pharmacies, 2023 and 2034
  • Figure 36: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Retail Pharmacies, 2020-2034
  • Figure 37: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Retail Pharmacies, 2023 and 2034
  • Figure 38: Global Proton Pump Inhibitors (PPIs) Market Value (US$ Mn), by Online Pharmacies, 2020-2034
  • Figure 39: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Online Pharmacies, 2023 and 2034
  • Figure 40: Global Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 41: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Region, 2023
  • Figure 42: Global Proton Pump Inhibitors (PPIs) Market Share Analysis, by Region, 2034
  • Figure 43: Global Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 44: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 45: North America Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 46: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 47: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 48: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 49: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 50: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 51: North America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 52: North America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 53: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 54: Europe Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 55: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 57: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 58: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 59: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 60: Europe Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 61: Europe Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 62: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 63: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 64: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 65: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 66: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 67: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 68: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 69: Asia Pacific Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 70: Asia Pacific Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 71: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 72: Latin America Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 73: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 74: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 75: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 76: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 77: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 78: Latin America Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 79: Latin America Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 80: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 81: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 82: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 83: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Drug Type, 2023 and 2034
  • Figure 84: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Drug Type, 2024-2034
  • Figure 85: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Indication Type, 2023 and 2034
  • Figure 86: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Indication Type, 2024-2034
  • Figure 87: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 88: Middle East & Africa Proton Pump Inhibitors (PPIs) Market Attractiveness Analysis, by Distribution Channel, 2024-2034